Brand profile · Biotechnology Research

Immunosis

Immunosis is a Biotechnology Research brand in Melbourne, VIC. Ownership is privately held; it publishes at immunosis.com. It holds one address on record, all in Australia. The record counts 3 people. One Australian registration (ABN) is a confirmed match. Its latest round on record is Private equity, with no amount recorded. It is listed alongside ten similar brands, mostly in Biotechnology Research.

immunosis.com LinkedIn

Profile live Privately Held 1 entity ABN 1 office country 1 funding round
Registry verified · ABR
Counted staff
3
self-reported 2–10 band
Founded
Not recorded
Legal entities
1
ABR
Office countries
1
1 address
Funding rounds
1
Private equity · Feb 2021
Company type
Privately Held
self-reported
Use this profile Compare Your shortlist

Legal entity

1 brand → 1 confirmed entity

  • IMMUNOSIS PTY LTD

    ABN35609513162

    VICHigh confidenceMatched on exact nameABR

Legal entities

Immunosis: 1 registry entityImmunosis is linked to 1 registry entity: IMMUNOSIS PTY LTD (ABN 35609513162, candidate).ImmunosisIMMUNOSIS PTY LTDABN 35609513162Candidate · High confidence
Show as table
IMMUNOSIS PTY LTDABN 35609513162
Confirmed matches0 of 1

A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.

Description

Immunosis is a startup company developing a diagnostic platform technology that can be used to diagnose patients with immune dysfunctions.

Locations

Australiaprimary

Country footprint

Offices in 1 countryCountry footprint: 1 country, primary AU. Codes: AU.1 countryprimary AUAU
Show as table
Countries1
Primary countryAU

All codes: AU

Addresses

  • AUMelbourne, VICPrimary

Grid intelligence Members

Funding

Last round · 1 February 2021Amount not recordedPrivate equity
Rounds1
Round typePrivate equity · venture round
Amount (USD)not recorded
Stage rank6
Investors named0
Since last round4 yr 11 mo

Funding

1 funding roundFunding timeline. Latest round 1 Feb 2021: Private equity, amount not disclosed.20212026Private equityamount not disclosed1 round
Show as table
Rounds1
Axis2021 to 2026
Private equity · 1 Feb 2021not disclosed

Dated rounds only. The axis ends at the date this profile was last observed, not at today.

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Notify me about spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend
Notify me about signals

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
Notify me about financials

People & contacts

2 employee profiles on record · names withheld.

Counts only. No names are stored here, and none are served.

Notify me about contacts Tell us who you need to reach and we will tell you when a consented source is live.

FAQ

Which legal entity operates under Immunosis?

One Victoria entity on the ABR. IMMUNOSIS PTY LTD (ABN 35 609 513 162), high confidence.

How many people work at Immunosis?

The record holds 3 counted staff profiles at January 2026, inside the self-reported 2–10 band.

Where does Immunosis have offices?

One address on record, Australia only. Primary: Melbourne, VIC.

Has Immunosis raised funding?

One round. Latest 1 February 2021: private equity, no amount recorded.

Which companies are listed alongside Immunosis?

13 profiles list Immunosis as a peer — 87th percentile in Biotechnology Research. It lists ten peers of its own. Proxima Bio and Inosi Therapeutics Pty Ltd list it back.

What is Immunosis's website?

immunosis.com